Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Aurora Cannabis

Canopy Growth

Cronos Group

Innovative Industrial Properties

Akerna Corp

Amplify Alternative Harvest ETF

Tilray Brands

Cambria Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal.

Are Any Canadian Marijuana Stocks Good Buys As Earnings Disappoint?

The ambitious U.S. company wants to place a wedge in the big European country.

Curaleaf Rolls Out Medical Pot Products in Germany

Curaleaf reported strong Q1 results. The leading MSO guided Q2 revenues up 19% sequentially to $310 million.

Curaleaf: Still The Cannabis Leader

Low volatility weed stocks that are best positioned to benefit from industry tailwinds and potential cannabis legalization at federal level. The post 4 of the Least Volatile Weed Stocks appeared first on InvestorPlace.

4 of the Least Volatile Weed Stocks

Cannabis company Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF) reported having earned $260 million in the first three months of 2021, representing an increase of 170% year-over-year and 13% sequentially. Adjusted EBITDA came in positive at $63 million, up by 213% year-over-year and 16% quarter-over-quarter.

Curaleaf Achieves Record Q1 Revenue Of $260M, Adjusted EBITDA, Exceeds Its Guidance

Earnings may be at an inflection point for the world's biggest legal seller of cannabis. CEO Boris Jordan hopes for modest reforms of federal cannabis laws.

As U.S. Cannabis Sales Boom, Curaleaf Sees Its Growth Accelerating

Curaleaf Holdings Inc.'s stronger-than-expected first-quarter earnings have put the company on track to deliver above-consensus numbers for 2021 and beat its own guidance for full-year revenue of $1.2 billion to $1.3 billion, analysts said Tuesday.

Cannabis Watch: Curaleaf's strong quarter sets it up for a better-than-expected year — and that's without sales in New York and New Jersey

Curaleaf Holdings (OTC: CURLF) posted its first-quarter 2021 financial results on Monday with total revenue of $260.32 million, up by 170% from the same period of 2020. The cannabis company reported a positive adjusted EBITDA of $62.63 million, which compares to $20 million in the same quarter of the prior year.

Analyst: Cannabis Co. Curaleaf Could Easily Reach Its Full-Year Sales Targets Of $1.3 Billion

GrowGeneration Corp

Jazz Pharmaceuticals

SNDL Inc.

Trulieve Cannabis Corp.

And ignoring it could cost you significant returns.

Warren Buffett Has a Warning for Growth Investors

Poised for Rapid Growth in Europe's Largest Medical Cannabis Market WAKEFIELD, Mass., May 11, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that wholly owned Curaleaf International subsidiary Adven GmbH ("Adven") has launched its own range of medical cannabis products in Germany, Europe's largest medical cannabis market.

Curaleaf International Launches Range of Medical Cannabis Products in Germany

This U.S. cannabis company is firing on all cylinders.

Curaleaf Blows Past Expectations in Q1 With Even Bigger Opportunities Ahead

Curaleaf Holdings Inc (CNSX:CURA) has celebrated fresh highs for its finances after its revenues and earnings hit record levels in the first quarter of 2021. The US's largest cannabis group reported record revenues of US$260mln in the three month period, up 170% year-on-year, while adjusted earnings (EBITDA) rose 213% to a record level of US$63mln.

Curaleaf on a high as sales and earnings hit record levels

LONDON--(BUSINESS WIRE)--Curaleaf International (formerly EMMAC Life Sciences Group), Europe's largest vertically integrated cannabis company, is pleased to announce that its wholly owned subsidiary, Adven GmbH (“Adven”), has launched its own range of medical cannabis products in Germany, Europe's largest medical cannabis market. The initial product launch of a high THC oil product is to meet immediate patient demand and will be extended over the course of the year to incorporate a number of di

Curaleaf International Launches Own Range of Medical Cannabis Products in Germany

Curaleaf Holdings, Inc. (CURLF) CEO Joe Bayern on Q1 2021 Results - Earnings Call Transcript

The quarter wasn't necessarily a bad one, but a big new competitor looms.

Curaleaf Falls by Over 4% on Q1 Results

Curaleaf Holdings Inc. is selling cannabis at an annual rate of a billion dollars a year, and executives expect that to keep increasing.

Earnings Results: U.S. cannabis company Curaleaf reaches billion-dollar annual sales rate

WAKEFIELD, Mass., May 10, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the first quarter ended March 31, 2021.

Curaleaf Reports Record First Quarter 2021 Financial and Operational Results

Green Thumb Industries Inc.

These 2 Marijuana Stocks Are Starting To Climb Back Up In May The post Marijuana Stocks Are On The Move But Will Trading Continue To Rise This Month? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Marijuana Stocks Are On The Move But Will Trading Continue To Rise This Month?

Top US Marijuana Stocks For The Second Week In May The post The Best Marijuana Stocks To Buy For 2021? 3 Top US Pot Stocks Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

The Best Marijuana Stocks To Buy For 2021? 3 Top US Pot Stocks Right Now

Village Farms International

These companies are all managing to grow while generating positive cash flow, which is no easy feat in this industry.

4 Cannabis Companies Actually Making Money

Both states notched fresh monthly records.

April Marijuana Sales in Oregon, Illinois Set New Highs

HEXO Corp

Returns in weed stocks have been all over the place, and largely based on geography. Here's where 10 of the biggest names stand now.

The 10 Hottest Weed Stocks On the Market For May

Completes Acquisition of New, Larger Cultivation Site in Taneytown Updates Further Strengthen Curaleaf's Position as a Leading Cannabis Operator in the State WAKEFIELD, Mass., May 4, 2021 /PRNewswire/ --  Curaleaf Holdings, Inc.  (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, announces the completion of the previously announced reorganization of its Maryland business.

Curaleaf Announces Changes to Footprint in Maryland

WAKEFIELD, Mass., May 3, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that Executive Chairman Boris Jordan and Chief Executive Officer Joe Bayern will be participating in the following investor community conferences and events during May 2021.

Curaleaf Announces Upcoming Investor Community Conference and Event Participation

Greenlane Holdings

cbdMD Inc

Delic Holdings Appoints Dr. Eric Janusson As Lead Chemist Complex Biotech Discovery Ventures Ltd., a licensed cannabis and psilocybin research laboratory, has appointed Dr. Eric Janusson as its lead chemist.

Cannabis Movers & Shakers: Fire & Flower, Acreage, cbdMD, Greenlane & KushCo, Digital Venture

News for Curaleaf Holdings, Inc. Stock (CURLF)